These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 31651282)

  • 21. Non-invasive PET imaging of EGFR degradation induced by a heat shock protein 90 inhibitor.
    Niu G; Cai W; Chen K; Chen X
    Mol Imaging Biol; 2008; 10(2):99-106. PubMed ID: 18157579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monitoring reversal of MET-mediated resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer using 3'-deoxy-3'-[18F]-fluorothymidine positron emission tomography.
    Iommelli F; De Rosa V; Gargiulo S; Panico M; Monti M; Greco A; Gramanzini M; Ortosecco G; Fonti R; Brunetti A; Del Vecchio S
    Clin Cancer Res; 2014 Sep; 20(18):4806-15. PubMed ID: 25052479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis, and validation of Axl-targeted monoclonal antibody probe for microPET imaging in human lung cancer xenograft.
    Liu S; Li D; Guo J; Canale N; Li X; Liu R; Krasnoperov V; Gill PS; Conti PS; Shan H; Li Z
    Mol Pharm; 2014 Nov; 11(11):3974-9. PubMed ID: 24978094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 3'-deoxy-3'-18F-fluorothymidine PET/CT to guide therapy with epidermal growth factor receptor antagonists and Bcl-xL inhibitors in non-small cell lung cancer.
    Zannetti A; Iommelli F; Speranza A; Salvatore M; Del Vecchio S
    J Nucl Med; 2012 Mar; 53(3):443-50. PubMed ID: 22331221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of cetuximab alone and in combination with radiation and/or chemotherapy in lung cancer.
    Raben D; Helfrich B; Chan DC; Ciardiello F; Zhao L; Franklin W; Barón AE; Zeng C; Johnson TK; Bunn PA
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):795-805. PubMed ID: 15701870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor Hypoxia Response After Targeted Therapy in EGFR-Mutant Non-Small Cell Lung Cancer: Proof of Concept for FMISO-PET.
    Arvold ND; Heidari P; Kunawudhi A; Sequist LV; Mahmood U
    Technol Cancer Res Treat; 2016 Apr; 15(2):234-42. PubMed ID: 25759424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, Synthesis, and Biological Evaluation of
    Liu F; Liu T; Xu X; Guo X; Li N; Xiong C; Li C; Zhu H; Yang Z
    Mol Pharm; 2018 Feb; 15(2):619-628. PubMed ID: 29278911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ImmunoPET Imaging of CTLA-4 Expression in Mouse Models of Non-small Cell Lung Cancer.
    Ehlerding EB; England CG; Majewski RL; Valdovinos HF; Jiang D; Liu G; McNeel DG; Nickles RJ; Cai W
    Mol Pharm; 2017 May; 14(5):1782-1789. PubMed ID: 28388076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined treatment with cetuximab and STA9090 has synergistic anticancer effects on human non-small cell lung cancer.
    Lu W; Liu L; Kang X; Ren K; Huang Y; Cheng M; Li X; Xu F; Xu X
    Acta Biochim Biophys Sin (Shanghai); 2024 May; 56(7):1022-1033. PubMed ID: 38818581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular imaging of active mutant L858R EGF receptor (EGFR) kinase-expressing nonsmall cell lung carcinomas using PET/CT.
    Yeh HH; Ogawa K; Balatoni J; Mukhapadhyay U; Pal A; Gonzalez-Lepera C; Shavrin A; Soghomonyan S; Flores L; Young D; Volgin AY; Najjar AM; Krasnykh V; Tong W; Alauddin MM; Gelovani JG
    Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1603-8. PubMed ID: 21220318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PET probe detecting non-small cell lung cancer susceptible to epidermal growth factor receptor tyrosine kinase inhibitor therapy.
    Makino A; Miyazaki A; Tomoike A; Kimura H; Arimitsu K; Hirata M; Ohmomo Y; Nishii R; Okazawa H; Kiyono Y; Ono M; Saji H
    Bioorg Med Chem; 2018 May; 26(8):1609-1613. PubMed ID: 29478801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Affibody-Based PET Imaging to Guide EGFR-Targeted Cancer Therapy in Head and Neck Squamous Cell Cancer Models.
    Burley TA; Da Pieve C; Martins CD; Ciobota DM; Allott L; Oyen WJG; Harrington KJ; Smith G; Kramer-Marek G
    J Nucl Med; 2019 Mar; 60(3):353-361. PubMed ID: 30213849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved Immuno-PET Imaging of HER2-Positive Tumors in Mice: Urokinase Injection-Triggered Clearance Enhancement of
    Ren Q; Mohri K; Warashina S; Wada Y; Watanabe Y; Mukai H
    Mol Pharm; 2019 Mar; 16(3):1065-1073. PubMed ID: 30633529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive efficacy of (11)C-PD153035 PET imaging for EGFR-tyrosine kinase inhibitor sensitivity in non-small cell lung cancer patients.
    Dai D; Li XF; Wang J; Liu JJ; Zhu YJ; Zhang Y; Wang Q; Xu WG
    Int J Cancer; 2016 Feb; 138(4):1003-12. PubMed ID: 26334931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and preliminary evaluation of
    Lu X; Wang C; Li X; Gu P; Jia L; Zhang L
    Bioorg Med Chem; 2019 Feb; 27(3):545-551. PubMed ID: 30611635
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Pyo A; Yun M; Kim HS; Kim TY; Lee JJ; Kim JY; Lee S; Kwon SY; Bom HS; Kim HS; Kim DY; Min JJ
    J Nucl Med; 2018 Feb; 59(2):340-346. PubMed ID: 28916621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of conjugation strategies of cross-bridged macrocyclic chelators with cetuximab for copper-64 radiolabeling and PET imaging of EGFR in colorectal tumor-bearing mice.
    Zeng D; Guo Y; White AG; Cai Z; Modi J; Ferdani R; Anderson CJ
    Mol Pharm; 2014 Nov; 11(11):3980-7. PubMed ID: 24720806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring pitfalls of
    Striese F; Sihver W; Gao F; Bergmann R; Walther M; Pietzsch J; Steinbach J; Pietzsch HJ
    Amino Acids; 2018 Oct; 50(10):1415-1431. PubMed ID: 30039310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immuno-OpenPET: a novel approach for early diagnosis and image-guided surgery for small resectable pancreatic cancer.
    Yoshii Y; Tashima H; Iwao Y; Yoshida E; Wakizaka H; Akamatsu G; Yamaya T; Matsumoto H; Yoshimoto M; Igarashi C; Hihara F; Tachibana T; Zhang MR; Nagatsu K; Sugyo A; Tsuji AB; Higashi T
    Sci Rep; 2020 Mar; 10(1):4143. PubMed ID: 32157106
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Kruziki MA; Case BA; Chan JY; Zudock EJ; Woldring DR; Yee D; Hackel BJ
    Mol Pharm; 2016 Nov; 13(11):3747-3755. PubMed ID: 27696863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.